Long-term renal graft outcome after parathyroidectomy-a retrospective single centre study

M Patecki, I Scheffner, H Haller, W Gwinner - BMC nephrology, 2020 - Springer
Background Surgical correction of hyperparathyroidism after kidney transplantation has
been associated with significant graft function decline. We examined the effects of …

Impact of cinacalcet pre‐transplantation on mineral metabolism in renal transplant recipients

AK Sharma, R Masterson, SG Holt, SJ Tan… - …, 2016 - Wiley Online Library
Aim Cinacalcet is effective in reducing parathyroid hormone (PTH) in patients on dialysis.
Reports of biochemical profiles and other clinical outcomes in patients discontinuing …

[PDF][PDF] Tratamiento eficaz de la arteriolopatía urémica calcificante con bifosfonatos

JV Torregrosa, CE Durán, X Barros, M Blasco… - Nefrología …, 2012 - SciELO Espana
TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …

Surgery is underutilized in the management of tertiary hyperparathyroidism

AM Delman, KM Turner, M Ahmad, LAS Silski… - Journal of Surgical …, 2022 - Elsevier
Introduction Tertiary hyperparathyroidism (3HPT) is observed in up to 40% of renal
transplant patients. Standard guidelines defining 3HPT and indications for operative …

Retrospective study looking at cinacalcet in the management of hyperparathyroidism after kidney transplantation

H Mawad, H Bouchard, D Tran, D Ouimet… - Journal of …, 2017 - Wiley Online Library
Objectives. The primary objective of this study is to evaluate the use of cinacalcet in the
management of hyperparathyroidism in kidney transplant recipients. The secondary …

The effect of cinacalcet on hypercalcemia in kidney transplant patients with hyperparathyroidism: systematic review and meta-analysis

H Fooladi, FV Torfi, A Khodaparast… - Journal of Renal Injury …, 2023 - journalrip.com
Introduction: Following renal transplantation, patients with end-stage renal disease develop
parathyroid dysfunction and electrolyte abnormalities, including calcium and phosphate …

[引用][C] 盐酸西那卡塞在治疗甲状旁腺功能亢进中的研究进展

谭秀艳, 张敏敏, 李中东, 陈靖 - 中国医院药学杂志, 2017

[HTML][HTML] Association between resistance to cinacalcet and parathyroid gland hyperplasia in kidney transplant recipients with persistent hypercalcemia

A Oruc, A Ersoy, AA Kocaeli, A Yildiz… - … Journal of Organ …, 2020 - ncbi.nlm.nih.gov
Background: Persistent hypercalcemia and hyperparathyroidism after successful kidney
transplantation can be detrimental in some recipients and should be ameliorated. Objective …

Parathyroidectomy or calcimimetic to treat hypercalcemia after kidney transplantation?

M Fukagawa, TB Drüeke - Journal of the American Society of …, 2016 - journals.lww.com
8. Tögel FE, Westenfelder C: Mesenchymal stem cells: a new therapeutic tool for AKI. Nat
Rev Nephrol 6: 179–183, 2010 9. Tögel FE, Westenfelder C: Kidney protection and …

肾移植后骨异常研究进展

刘萍, 巩栋, 张利平 - 肾脏病与透析肾移植杂志, 2018 - njcndt.com
肾移植后骨异常主要表现为骨量丢失, 矿化异常和易发骨折. 终末期肾病的众多并发症可通过
成功的肾移植改善, 然而由于大部分患者移植前就存在肾性骨营养不良, 移植后甲状旁腺激素 …